Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
Children's Health | Immune System | Men's Health | Women's Health
What is the purpose of this trial?
This is a multi-center, open-label trial to evaluate safety and pharmacokinetics of topical delgocitinib cream applied to pediatric subjects(2-17 years) and adult subjects (18 years and above) with atopic dermatitis.
- Ages2 years and older
- Trial withLEO Pharma A/S
- Start Date12/06/2019
- End Date05/16/2020
- Last Updated07/15/2021
- Study HIC#2000025015